Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Eur Rev Med Pharmacol Sci ; 24(21): 11072-11080, 2020 11.
Article in English | MEDLINE | ID: mdl-33215423

ABSTRACT

OBJECTIVE: The purpose of this study was to explore the expression and biological functions of long non-coding ribonucleic acid (lncRNA) ribonuclease P RNA component H1 (RPPH1) in gastric cancer (GC), and to analyze the correlations of lncRNA expression with the clinical features and prognosis of GC patients. PATIENTS AND METHODS: The relative expression of RPPH1 in tissue specimens from 60 GC patients was measured via quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR), and the correlations of RPPH1 expression with tumor-node-metastasis (TNM) stage, lymph node metastasis, etc. in GC patients were analyzed. Then, qRT-PCR was performed to detect the relative expression level of RPPH1 in GC cells. Moreover, colony formation assay, 5-Ethynyl-2'-deoxyuridine (EdU) staining, wound-healing assay, and transwell assay were employed to investigate the influence of RPPH1 on GC cell functions. After interfering in the expression of RPPH1, the changes in p21 (CDKN1A, cyclin dependent kinase inhibitor 1A) expression were determined through qRT-PCR and Western blotting. RESULTS: It was shown in qRT-PCR assay results that the expression of RPPH1 was upregulated in 60 cases of GC tissues. Statistical analysis revealed that RPPH1 expression was positively correlated with the TNM stage, lymph node metastasis, and infiltration depth in GC patients. Besides, highly expressed lncRNA RPPH1 suggested poor prognosis of GC patients. Based on the results of qRT-PCR assay, the expression of RPPH1 in GC cells was upregulated. After interfering in RPPH1 expression, both colony formation assay and EdU staining indicated that the proliferative capacity of GC cells was repressed. Furthermore, it was manifested in the results of wound-healing and transwell assays that the migratory and invasive abilities of GC cells were weakened. Finally, the qRT-PCR and Western blotting assay results demonstrated that p21 expression was upregulated after interfering in the expression of RPPH1 in GC cells. CONCLUSIONS: The expression of lncRNA RPPH1 is upregulated in GC, suggesting that the prognosis of the patients is poor. Highly expressed RPPH1 promotes the proliferation and metastasis of GC cells by regulating p21 expression.


Subject(s)
Cyclin-Dependent Kinase Inhibitor p21/genetics , RNA, Long Noncoding/metabolism , Stomach Neoplasms/metabolism , Cell Movement , Cell Proliferation , Cells, Cultured , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Female , Humans , Male , Middle Aged , Prognosis , RNA, Long Noncoding/genetics , Stomach Neoplasms/diagnosis
2.
Vet Parasitol ; 241: 52-60, 2017 Jul 15.
Article in English | MEDLINE | ID: mdl-28579032

ABSTRACT

A great deal of evidence demonstrates that a strongly clonal population structure of Toxoplasma gondii strains exists in humans and animals in North America and Europe, while the strains from South America are genetically separate and more diverse. Potential differences in virulence between different strains mean that an understanding of strain diversity is important to human and animal health. However, to date, only one predominant genotype, ToxoDB#9 (Chinese I), and a few other genotypes, including ToxoDB#205, have been identified in China. By using DNA sequence-based phylogenetic analyses, we have re-evaluated the population structure of T. gondii strains collected from China and compared them with other global strains. Based on phylogenetic analysis of restriction fragment length polymorphisms, multilocus sequence typing and intron sequences from T. gondii, we propose that the Chinese isolates described as Chinese I are divided into two groups called Chinese I and Chinese III. Our results demonstrate that significant differences were found in mouse mortality caused by some Chinese strains, and also the archetypal I, II, III strains in mice. Furthermore, a comparison of cyst loading in the brains of infected rats showed some Chinese strains to be capable of a high degree of cyst formation. Furthermore we show that genotyping using neutral genetic markers may not be a useful predictor of pathogenic phenotypes.


Subject(s)
Genotype , Toxoplasma/genetics , Toxoplasma/pathogenicity , Toxoplasmosis, Animal/parasitology , Animals , China/epidemiology , Female , Mice , Phylogeny , Polymorphism, Genetic , Toxoplasmosis, Animal/epidemiology , Virulence
3.
Clin Microbiol Infect ; 22 Suppl 1: S9-14, 2016 Mar.
Article in English | MEDLINE | ID: mdl-27000156

ABSTRACT

With the aim of gathering temporal trends on bacterial epidemiology and resistance from multiple laboratories in China, the CHINET surveillance system was organized in 2005. Antimicrobial susceptibility testing was carried out according to a unified protocol using the Kirby-Bauer method or automated systems. Results were analyzed according to Clinical and Laboratory Standards Institute (CLSI) 2014 definitions. Between 2005 and 2014, the number of bacterial isolates ranged between 22,774 and 84,572 annually. Rates of extended-spectrum ß-lactamase production among Escherichia coli isolates were stable, between 51.7 and 55.8%. Resistance of E. coli and Klebsiella pneumoniae to amikacin, ciprofloxacin, piperacillin/tazobactam and cefoperazone/sulbactam decreased with time. Carbapenem resistance among K. pneumoniae isolates increased from 2.4 to 13.4%. Resistance of Pseudomonas aeruginosa strains against all of antimicrobial agents tested including imipenem and meropenem decreased with time. On the contrary, resistance of Acinetobacter baumannii strains to carbapenems increased from 31 to 66.7%. A marked decrease of methicillin resistance from 69% in 2005 to 44.6% in 2014 was observed for Staphylococcus aureus. Carbapenem resistance rates in K. pneumoniae and A. baumannii in China are high. Our results indicate the importance of bacterial surveillance studies.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Gram-Negative Bacteria/isolation & purification , Gram-Negative Bacterial Infections/epidemiology , China/epidemiology , Gram-Negative Bacteria/drug effects , Gram-Negative Bacterial Infections/microbiology , Humans , Microbial Sensitivity Tests , Population Surveillance
4.
Eur Rev Med Pharmacol Sci ; 20(2): 381-90, 2016.
Article in English | MEDLINE | ID: mdl-26875911

ABSTRACT

OBJECTIVE: The new antifungal agents provide further opportunities for effective prophylaxis for fungal infections during stem cell transplantation for patients with hematologic malignancies; however, the efficacy of these antifungal prophylactic drugs has not yet been established. This study was to compare the newer antifungal agents micafungin and voriconazole for prophylaxis effects on the clinical outcomes. MATERIALS AND METHODS: We electronically searched the database of Cochrane Central Register of Controlled Trials, Pubmed, EMbase, and relevant database articles (1996.01-2013.12). Comparative studies were carried out on proved fungal infections, mortality, and adverse effects. Meta-analysis was performed by Review Manager 5.1.6 software and the funnel plot regression was adopted to assess the publication bias. RESULTS: We found 1508 records and 13 studies totaling 3767 patients included in analyses. Pooled comparisons of studies found that antifungal prophylaxis with the new agents does reduce the incidence of invasive fungal infections than fluconazole or itraconazole. The reduction in invasive fungal infections was achieved by using micafungin, voriconazole for antifungal prophylaxis. Using voriconazole prophylaxis can decrease the transplant mortality compared with fluconazole or itraconazole prophylaxis. Voriconazole had higher rates of liver dysfunction, lower gastrointestinal side effects over fluconazole, and lower rates of nephrotoxic effects than amphotericin B. Both micafungin and voriconazole had a significant decrease in adverse events requiring drug discontinuation compared with itraconazole. CONCLUSIONS: This analysis indicated the 2 agents appear to be well tolerated with manageable side effects and beneficial in the prophylaxis of IFI. Further work is needed with a large scale of random controlled trials on the effect of these drugs.


Subject(s)
Antifungal Agents/therapeutic use , Echinocandins/therapeutic use , Hematopoietic Stem Cell Transplantation , Lipopeptides/therapeutic use , Mycoses/drug therapy , Voriconazole/therapeutic use , Fluconazole/therapeutic use , Humans , Incidence , Itraconazole/therapeutic use , Micafungin , Randomized Controlled Trials as Topic
5.
Insect Mol Biol ; 24(4): 442-53, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25824261

ABSTRACT

G protein-coupled receptors (GPCRs) are the largest and most versatile superfamily of cell membrane proteins, which mediate various physiological processes including reproduction, development and behaviour. The diamondback moth, Plutella xylostella (Lepidoptera: Plutellidae), is one of the most notorious insect pests, preferentially feeding on cruciferous plants. P. xylostella is not only one of the world's most widespread lepidopteran insects, but has also developed resistance to nearly all classes of insecticides. Although the mechanisms of insecticide resistance have been studied extensively in many insect species, few investigations have been carried out on GPCRs in P. xylostella. In the present study, we identified 95 putative GPCRs in the P. xylostella genome. The identified GPCRs were compared with their homologues in Bombyx mori and Drosophila melanogaster. Our results suggest that GPCRs in different insect species may have evolved by a birth-and-death process. One of the differences among compared insects is the duplication of short neuropeptide F receptor and adipokinetic hormone receptors in P. xylostella and B. mori. Another divergence is the decrease in quantity and diversity of the stress-tolerance gene, Mth, in P. xylostella. The evolution by the birth-and-death process is probably involved in adaptation to the feeding behaviour, reproduction and stress responses of P. xylostella. Some of the genes identified in the present study could be potential targets for the development of novel pesticides.


Subject(s)
Insect Proteins/genetics , Insecticide Resistance/genetics , Moths/genetics , Receptors, G-Protein-Coupled/genetics , Animals , Biological Evolution , Bombyx/genetics , Drosophila melanogaster/genetics , Genome, Insect , Phylogeny , Sequence Analysis, Protein
6.
Eur Rev Med Pharmacol Sci ; 18(17): 2465-74, 2014.
Article in English | MEDLINE | ID: mdl-25268091

ABSTRACT

Although treatment results for adult acute lymphoblastic leukemia (ALL) have improved considerably in the past decades, treating adult patients with relapsed/refractory acute lymphocytic leukemia (ALL) is still difficult. Adults with refractory/relapsed acute lymphocytic leukemia (ALL) processed to death rapidly associated with chemotherapy resistance, high mortality by reinduction, etc. Only 20% to 30% of those patients acquired complete remission (CR). Those patients are always of short duration unless an allogeneic stem cell transplant is feasible. Median survival is only ranging from 2 to 12 months. Therapeutic strategy on relapsed/refractory acute lymphocytic leukemia (ALL) is always a major therapeutic challenge bothering hematological researchers. Novel agents and unique therapeutic strategies have been developed in recent years. This review focuses on major clinical advances in the agents for refractory/relapsed ALL.


Subject(s)
Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Adult , Female , Humans , Male , Neoplasm Recurrence, Local/drug therapy , Salvage Therapy , Young Adult
7.
Transplant Proc ; 45(1): 407-14, 2013.
Article in English | MEDLINE | ID: mdl-23375330

ABSTRACT

OBJECTIVE: The efficacy of newer antifungal agents to provide effective prophylaxis during stem cell transplantation has not yet been established. We compared the clinical outcomes using of the newer triazoles and echinocandins for antifungal prophylaxis. METHODS: We electronically searched the databases of Cochrane Central Register of Controlled Trials, Pubmed, EMBASE, and relevant articles from 1987 through 2011. We examined comparative studies for survival, proven fungal infections, mortality, and adverse effects. Our meta-analysis was performed by Review Manager 5.1.6 software with funnel plot regression analysis to assess publication bias. RESULTS: Among 1443 records were 17 studies including 5122 patients for analyses. Pooled comparisons of studies showed antifungal prophylaxis with the new agents to reduce the incidence of invasive fungal infections greater than fluconazole or itraconazole. A reduction in invasive fungal infections was achieved using micafungin, voriconazole, and posaconazole for antifungal prophylaxis. Posaconazole and voriconazole prophylaxis decreased transplant mortality compared with fluconazole or itraconazole prophylaxis. Voriconazole and posaconzole showed greater rates of liver dysfunction and lower incidences gastrointestinal side effects than fluconazole. Caspofungin and voriconazole treatment incurred lower rates of nephrotoxic effects than amphotericin B. Only voriconazole displayed significantly decreased adverse events requiring drug discontinuation compared with fluconazole or itraconazole. CONCLUSIONS: This analysis indicated new antifungal agents were well-tolerated with manageable side effects. They were beneficial for prophylaxis of invasive fungal infections.


Subject(s)
Antifungal Agents/pharmacology , Hematopoietic Stem Cell Transplantation/methods , Mycoses/drug therapy , Mycoses/prevention & control , Hematopoietic Stem Cell Transplantation/adverse effects , Humans , Mycoses/complications , Randomized Controlled Trials as Topic , Stem Cell Transplantation/methods , Treatment Outcome , Triazoles/therapeutic use
8.
J Int Med Res ; 40(5): 1919-30, 2012.
Article in English | MEDLINE | ID: mdl-23206476

ABSTRACT

OBJECTIVE: This study investigated bilateral uterine artery chemoembolization (BUACE) combined with dilation and curettage (D&C) in caesarean scar pregnancy (CSP). METHODS: Nineteen women with CSP were referred for interventional radiology. In 13 patients, BUACE was performed before D&C, following a diagnosis of CSP. A further six patients received BUACE for massive vaginal bleeding after D&C for inevitable miscarriage; the diagnosis of CSP was subsequently confirmed ultrasonographically. BUACE of the uterine arteries was performed using gelfoam particles following intra-arterial infusion of 100 mg/m(2) methotrexate. RESULTS: BUACE was technically successful and immediate haemostasis was achieved in all patients. Blood loss was significantly greater during D&C undertaken before BUACE compared with D&C after BUACE, but this bleeding was controlled by BUACE. No patient required further surgical intervention and there were no severe complications. The gestational sac and placenta could no longer be detected ultrasonographically and the menstrual cycle returned to normal 2-3 months after treatment in all patients. CONCLUSIONS: BUACE followed by D&C seems to be a safe and effective treatment for CSP and should be considered as a treatment of choice.


Subject(s)
Chemoembolization, Therapeutic , Dilatation and Curettage , Pregnancy, Ectopic/therapy , Adult , Cesarean Section , Cicatrix , Combined Modality Therapy , Female , Humans , Myometrium/diagnostic imaging , Myometrium/pathology , Pregnancy , Pregnancy, Ectopic/diagnostic imaging , Treatment Outcome , Ultrasonography , Uterine Artery/pathology , Uterine Hemorrhage/therapy , Uterus/blood supply , Uterus/surgery , Young Adult
9.
Parasitology ; 139(2): 139-47, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22054357

ABSTRACT

Toxoplasmosis, caused by the protozoan parasite Toxoplasma gondii, is one of the most common parasitic infections in humans. Primary infection in pregnant women can be transmitted to the fetus leading to miscarriage or congenital toxoplasmosis. Carefully designed nationwide seroprevalence surveys and case-control studies of risk factors conducted primarily in Europe and America, have shaped our view of the global status of maternal and congenital infection, directing approaches to disease prevention. However, despite encompassing 1 in 5 of the world's population, information is limited on the status of toxoplasmosis in China, partly due to the linguistic inaccessibility of the Chinese literature to the global scientific community. By selection and analysis of studies and data, reported within the last 2 decades in China, this review summarizes and renders accessible a large body of Chinese and other literature and aims to estimate the seroprevalence in Chinese pregnant women. It also reviews the prevalence trends, risk factors, and clinical manifestations. The key findings are (1) the majority of studies show that the overall seroprevalence in Chinese pregnant women is less than 10%, considerably lower than a recently published global analysis; and (2) the few available appropriate studies on maternal acute infection suggested an incidence of 0·3% which is broadly comparable to studies from other countries.


Subject(s)
Toxoplasma , Toxoplasmosis/blood , Toxoplasmosis/epidemiology , China/epidemiology , Female , Humans , Pregnancy , Risk Factors , Seroepidemiologic Studies , Toxoplasmosis/pathology
11.
Nanoscale Res Lett ; 3(11): 427-30, 2008 Sep 30.
Article in English | MEDLINE | ID: mdl-21749734

ABSTRACT

The energy relaxation of electrons in γ-In2Se3nanorods was investigated by the excitation-dependent photoluminescence (PL). From the high-energy tail of PL, we determine the electron temperature (Te) of the hot electrons. TheTevariation can be explained by a model in which the longitudinal optical (LO)-phonon emission is the dominant energy relaxation process. The high-quality γ-In2Se3nanorods may be a promising material for the photovoltaic devices.

14.
Phys Rev Lett ; 75(8): 1677, 1995 Aug 21.
Article in English | MEDLINE | ID: mdl-10060360
15.
Phys Rev B Condens Matter ; 51(22): 16103-16110, 1995 Jun 01.
Article in English | MEDLINE | ID: mdl-9978592
16.
Phys Rev B Condens Matter ; 51(24): 17648-17653, 1995 Jun 15.
Article in English | MEDLINE | ID: mdl-9978794
18.
Phys Rev B Condens Matter ; 50(22): 16762-16765, 1994 Dec 01.
Article in English | MEDLINE | ID: mdl-9976071
20.
Phys Rev Lett ; 73(18): 2492-2495, 1994 Oct 31.
Article in English | MEDLINE | ID: mdl-10057073
SELECTION OF CITATIONS
SEARCH DETAIL
...